Resources from the same session
LBA6 - A phase II, single arm, open label, Simon two-stage study of pembrolizumab in metastatic HER2-negative breast cancer patients: Evaluation of impact of germline variants in APOBEC3B (AUROR)
Presenter: Gwo Fuang Ho
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
57MO - First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial
Presenter: Govind Babu Kanakasetty
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA3, LBA6 and 57MO
Presenter: Mastura Md Yusof
Session: Mini oral session: Breast cancer
Resources:
Slides